loading
Schlusskurs vom Vortag:
$21.46
Offen:
$21.55
24-Stunden-Volumen:
413.40K
Relative Volume:
0.91
Marktkapitalisierung:
$384.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.67%
1M Leistung:
+4.37%
6M Leistung:
-4.59%
1J Leistung:
-53.13%
1-Tages-Spanne:
Value
$19.00
$21.80
1-Wochen-Bereich:
Value
$18.99
$21.86
52-Wochen-Spanne:
Value
$13.70
$61.07

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Name
Firmenname
Tectonic Therapeutic Inc
Name
Telefon
(339) 666-3320
Name
Adresse
490 ARSENAL WAY, WATERTOWN
Name
Mitarbeiter
51
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
TECX's Discussions on Twitter

Vergleichen Sie TECX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TECX
Tectonic Therapeutic Inc
20.56 401.65M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
463.86 119.17B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
796.55 84.19B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
398.29 52.77B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
788.49 48.98B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
175.97 36.31B 447.02M -1.18B -906.14M -6.1812

Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-20 Eingeleitet Wells Fargo Overweight
2025-09-03 Eingeleitet Oppenheimer Outperform
2025-07-21 Eingeleitet Truist Buy
2025-06-11 Fortgesetzt Raymond James Outperform
2025-04-21 Eingeleitet Mizuho Outperform
2024-11-20 Eingeleitet Raymond James Outperform
2024-08-22 Eingeleitet Wells Fargo Overweight
2024-06-26 Eingeleitet Piper Sandler Overweight
2024-06-24 Eingeleitet TD Cowen Buy
2023-12-18 Herabstufung Mizuho Buy → Neutral
2022-01-05 Herabstufung BTIG Research Buy → Neutral
2021-11-19 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-06-15 Eingeleitet BTIG Research Buy
2021-05-27 Eingeleitet Needham Buy
2021-03-09 Eingeleitet Barclays Overweight
2021-03-02 Eingeleitet Stifel Hold
2020-11-11 Eingeleitet Berenberg Buy
2020-03-31 Herabstufung H.C. Wainwright Buy → Neutral
2019-06-27 Eingeleitet Mizuho Buy
2019-04-05 Eingeleitet Janney Buy
2018-10-10 Eingeleitet Guggenheim Buy
2018-10-02 Bestätigt H.C. Wainwright Buy
2018-09-17 Eingeleitet H.C. Wainwright Buy
2018-07-16 Eingeleitet Wedbush Outperform
2018-07-16 Eingeleitet Wells Fargo Outperform
Alle ansehen

Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten

pulisher
Jan 09, 2026

Breakout Move: Can Tectonic Therapeutic Inc stock sustain institutional interest2025 AllTime Highs & Fast Gain Swing Alerts - moha.gov.vn

Jan 09, 2026
pulisher
Jan 09, 2026

MSN Money - MSN

Jan 09, 2026
pulisher
Jan 09, 2026

Will Tectonic Therapeutic Inc. stock return to pre crisis levelsMarket Trend Report & Free High Accuracy Swing Entry Alerts - ulpravda.ru

Jan 09, 2026
pulisher
Jan 08, 2026

Is Tectonic Therapeutic Inc. stock a defensive play in 2025Weekly Earnings Recap & Weekly Sector Rotation Insights - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Can Tectonic Therapeutic Inc. stock sustain institutional interestMarket Performance Recap & Weekly Watchlist of Top Performers - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why Tectonic Therapeutic Inc. stock is popular among millennials2025 Big Picture & Weekly Market Pulse Updates - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Tectonic Therapeutic Inc. stock attractive for ETFsTrade Performance Summary & Reliable Price Breakout Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Tectonic Therapeutic Inc. stock recover faster than peersJuly 2025 Technicals & Safe Capital Allocation Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Can Tectonic Therapeutic Inc. stock beat analyst upgradesQuarterly Market Summary & Daily Entry Point Trade Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why Tectonic Therapeutic Inc. stock could benefit from AI revolution2025 Performance Recap & Low Risk High Win Rate Picks - ulpravda.ru

Jan 08, 2026
pulisher
Jan 07, 2026

TECTONIC THERAPEUTIC, INC. (TECX) - MSN

Jan 07, 2026
pulisher
Jan 07, 2026

Tectonic Therapeutic (TECX): LifeSci Capital reiterates buy rating - MSN

Jan 07, 2026
pulisher
Jan 01, 2026

Analysts Are Bullish on Top Healthcare Stocks: Tectonic Therapeutic (TECX), Ultragenyx Pharmaceutical (RARE) - The Globe and Mail

Jan 01, 2026
pulisher
Dec 25, 2025

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 25, 2025
pulisher
Dec 23, 2025

Hopeful Week For Insiders Who Bought US$51.1m Of Tectonic Therapeutic Stock - 富途牛牛

Dec 23, 2025
pulisher
Dec 20, 2025

Tectonic Therapeutic Earnings Notes - Trefis

Dec 20, 2025
pulisher
Dec 20, 2025

Can Tectonic Therapeutic Inc. stock deliver strong Q4 earnings2025 AllTime Highs & Verified Technical Trade Signals - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Will Tectonic Therapeutic Inc. stock benefit from green energy trendsJuly 2025 Institutional & Verified Technical Trade Signals - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Tectonic Therapeutic Inc. stock attractive after correctionJuly 2025 Decliners & Low Risk Entry Point Tips - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Tectonic Therapeutic (TECX) Receives a Buy from Wells Fargo - The Globe and Mail

Dec 19, 2025
pulisher
Dec 10, 2025

Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating - Finviz

Dec 10, 2025
pulisher
Dec 09, 2025

11 Best Micro-Cap Stocks to Invest in According to Analysts - Insider Monkey

Dec 09, 2025
pulisher
Dec 05, 2025

Will Tectonic Therapeutic Inc. stock continue upward momentumProfit Target & Community Consensus Trade Alerts - Newser

Dec 05, 2025
pulisher
Dec 03, 2025

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives $82.17 Average Target Price from Brokerages - Defense World

Dec 03, 2025
pulisher
Dec 02, 2025

Tectonic Therapeutic (TECX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 01, 2025

Tectonic Therapeutic to Participate in December Investor Conferences - The Manila Times

Dec 01, 2025
pulisher
Dec 01, 2025

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 01, 2025
pulisher
Nov 27, 2025

Its Stock Has Paid Off Big Time For Tectonic Therapeutic Inc - Setenews

Nov 27, 2025
pulisher
Nov 22, 2025

Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Nov 22, 2025
pulisher
Nov 20, 2025

Will Tectonic Therapeutic Inc. stock deliver long term returnsJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will Tectonic Therapeutic Inc. stock keep outperforming rivalsJuly 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Tectonic Therapeutic Inc. forming a reversal patternMarket Trend Report & Reliable Intraday Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What is the fair value of Tectonic Therapeutic Inc. stock nowWeekly Stock Recap & Accurate Buy Signal Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Tools to monitor Tectonic Therapeutic Inc. recovery probabilityTrade Exit Report & Weekly Stock Breakout Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Is Tectonic Therapeutic Inc. meeting your algorithmic filter criteriaEarnings Risk Summary & Safe Entry Zone Tips - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

How high can Tectonic Therapeutic Inc. stock goJuly 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com

Nov 18, 2025

Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)

Es liegen keine Finanzdaten für Tectonic Therapeutic Inc (TECX) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Tectonic Therapeutic Inc-Aktie (TECX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
McNamara Peter
Chief Scientific Officer
Dec 22 '25
Option Exercise
2.98
7,000
20,860
40,879
SPRINGER TIMOTHY A
Director
Apr 11 '25
Buy
16.31
53,706
875,945
1,503,358
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
16.73
45,858
767,204
1,449,652
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
14.76
21,071
311,020
1,403,794
SPRINGER TIMOTHY A
Director
Apr 11 '25
Buy
16.31
9,478
154,586
4,334,846
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
16.73
8,092
135,379
4,325,368
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
14.76
3,718
54,880
4,317,276
SPRINGER TIMOTHY A
Director
Apr 07 '25
Buy
17.10
412,500
7,053,750
1,382,723
SPRINGER TIMOTHY A
Director
Apr 07 '25
Buy
17.10
87,500
1,496,250
4,313,558
MCGUIRE TERRANCE
Director
Apr 07 '25
Sale
17.10
500,000
8,550,000
573,062
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Kapitalisierung:     |  Volumen (24h):